Qube Research & Technologies (QRT)
MET icon

Qube Research & Technologies (QRT)’s MetLife MET Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.06M Sell
71,580
-1,303,273
-95% -$105M 0.01% 1540
2026
Q1 		$97.2M Buy
1,374,853
+273,738
+25% +$20.5M 0.11% 224
2025
Q4 		$86.9M Buy
+1,101,115
New +$87.1M 0.09% 293
2025
Q3 		– Sell
-567,705
Closed -$44.7M – 3818
2025
Q2 		$45.7M Buy
567,705
+506,581
+829% +$39.1M 0.05% 506
2025
Q1 		$4.91M Buy
+61,124
New +$5.08M 0.01% 1546
2024
Q3 		– Sell
-270,167
Closed -$19M – 3800
2024
Q2 		$19M Buy
270,167
+92,979
+52% +$6.64M 0.03% 623
2024
Q1 		$13.1M Sell
177,188
-1,720,819
-91% -$120M 0.02% 728
2023
Q4 		$126M Buy
+1,898,007
New +$119M 0.24% 87
2023
Q3 		– Sell
-1,581,471
Closed -$98.5M – 4244
2023
Q2 		$89.4M Sell
1,581,471
-212,388
-12% -$11.8M 0.33% 82
2023
Q1 		$104M Buy
1,793,859
+604,448
+51% +$40.8M 0.45% 24
2022
Q4 		$86.1M Buy
1,189,411
+948,046
+393% +$67.9M 0.46% 24
2022
Q3 		$14.7M Buy
+241,365
New +$15.4M 0.09% 310
2021
Q3 		– Sell
-281,399
Closed -$16.8M – 2558
2021
Q2 		$16.8M Buy
+281,399
New +$17.8M 0.19% 103
2021
Q1 		– Sell
-67,388
Closed -$3.16M – 2218
2020
Q4 		$3.16M Buy
+67,388
New +$2.92M 0.05% 449
2020
Q3 		– Sell
-183,215
Closed -$6.69M – 1956
2020
Q2 		$6.69M Buy
+183,215
New +$6.38M 0.1% 263
2019
Q3 		– Sell
-9,559
Closed -$475K – 376
2019
Q2 		$475K Sell
9,559
-27,150
-74% -$1.28M 0.11% 186
2019
Q1 		$1.56M Buy
36,709
+25,030
+214% +$1.11M 0.21% 129
2018
Q4 		$480K Buy
11,679
+4,789
+70% +$205K 0.21% 127
2018
Q3 		$322K Sell
6,890
-2,538
-27% -$116K 0.04% 334
2018
Q2 		$411K Sell
9,428
-4,534
-32% -$211K 0.26% 80
2018
Q1 		$640K Buy
+13,962
New +$677K 0.25% 59

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MET Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its MetLife (MET) stake by 95% in Q2 2026, selling an estimated $105M and leaving 71,580 shares worth $6.06M. The position accounts for 0.01% of the portfolio, ranked #1540.

Qube Research & Technologies (QRT) first reported a position in MET in Q1 2018 and has held it in 21 quarters since. The position peaked at $126M in Q4 2023. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Qube Research & Technologies (QRT) held 71,580 shares of MetLife worth $6.06M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 1,303,273 MetLife shares in Q2 2026, an estimated $105M.
  • MetLife made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1540 holding.
  • Qube Research & Technologies (QRT) first reported a position in MetLife in Q1 2018 and has held it in 21 quarters since.
  • Qube Research & Technologies (QRT)'s MetLife position peaked at $126M in Q4 2023.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.